Amgen Inc (NAS:AMGN)
$ 264.49 0.49 (0.19%) Market Cap: 142.17 Bil Enterprise Value: 193.56 Bil PE Ratio: 33.87 PB Ratio: 18.89 GF Score: 89/100

Amgen Inc at Cowen Immuno-Oncology Next Summit (Virtual) Transcript

Nov 15, 2021 / 07:15PM GMT
Release Date Price: $207.4 (-1.89%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

All right. Well, good afternoon, everybody, and thank you for joining us again at this year's IO Summit. I'm Yaron Werber from the biotech team at Cowen. With me here today is my colleague, Gabe Schneider, and it's a great pleasure for both of us to co-moderate this session with Amgen.

Today, we have David Reese, who's EVP of R&D; and also Jean-Charles Soria, who's SVP, Global Development Oncology. So gentlemen, thank you so much for joining us. Really appreciate it.

David M. Reese
Amgen Inc. - EVP of Research & Development

Great to see you, Yaron.

Jean;Charles Soria
Amgen Inc. - SVP of Research & Development

Our pleasure.

Questions & Answers

Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

There's a lot to talk about. So we are focusing more on the IO pipeline,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot